Related Experiment Video
Updated: Apr 5, 2026

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
Published on: April 12, 2019
Osteosarcoma: Current Treatment and a Collaborative Pathway to Success.
Michael S Isakoff1, Stefan S Bielack1, Paul Meltzer1
1Michael S. Isakoff, Center for Cancer and Blood Disorders, Connecticut Children's Medical Center, Hartford, CT; Stefan S. Bielack, Klinikum Stuttgart, Olgahospital, Stuttgart, Germany; Paul Meltzer, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD; and Richard Gorlick, The Children's Hospital of Montefiore; Bronx, NY.
Osteosarcoma treatment improved significantly with chemotherapy, with high-dose methotrexate, doxorubicin, and cisplatin (MAP) regimens showing the best results. Further research and international collaboration are crucial for developing new therapies and improving survival rates for this bone cancer.
Area of Science:
- Pediatric Oncology
- Skeletal Oncology
- Cancer Chemotherapy
Background:
- Osteosarcoma is a prevalent bone tumor in young individuals.
- Historically, surgical resection was the primary treatment.
- Chemotherapy introduction dramatically improved survival rates for localized osteosarcoma.
Related Concept Videos
Treatment Resistant Cancers
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies
Treatment Resistent Cancers
Targeted Cancer Therapies
There are several types of targeted therapies against...
Targeted Cancer Therapies

